Neurocrine Biosciences Inc (NBIX) — Net Asset Momentum
Neurocrine Biosciences Inc (NBIX) recorded a net asset momentum of 25.6% as of December 2025, with net assets of $3.25 Billion USD. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. Check tangible net worth ratio of Neurocrine Biosciences Inc to evaluate the tangible quality of the company's equity base.
YoY Momentum
Current Net Assets
Years of Data
Country
Neurocrine Biosciences Inc Net Asset Momentum (1996–2025)
This chart tracks Neurocrine Biosciences Inc's year-over-year net asset growth across 30 annual reporting periods from 1996 to 2025. The most recent momentum reading is +25.6%, with net assets of $3.25 Billion USD as of December 2025. Read Neurocrine Biosciences Inc debt and liabilities for a breakdown of total debt and financial obligations.
Annual Net Asset History for Neurocrine Biosciences Inc (1996–2025)
The table below shows the complete annual net asset history for Neurocrine Biosciences Inc from 1996 to 2025, covering 30 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see NBIX market cap.
| Year | Net Assets (USD) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | $3.25 Billion | $4.63 Billion | $1.38 Billion | ▲ +25.6% |
| 2024 | $2.59 Billion | $3.72 Billion | $1.13 Billion | ▲ +16.0% |
| 2023 | $2.23 Billion | $3.25 Billion | $1.02 Billion | ▲ +30.7% |
| 2022 | $1.71 Billion | $2.37 Billion | $660.90 Million | ▲ +24.3% |
| 2021 | $1.37 Billion | $2.07 Billion | $698.50 Million | ▲ +22.0% |
| 2020 | $1.13 Billion | $1.73 Billion | $608.50 Million | ▲ +76.8% |
| 2019 | $636.90 Million | $1.31 Billion | $669.10 Million | ▲ +32.5% |
| 2018 | $480.76 Million | $993.15 Million | $512.39 Million | ▲ +29.2% |
| 2017 | $372.14 Million | $817.59 Million | $445.45 Million | ▲ +18.2% |
| 2016 | $314.88 Million | $365.09 Million | $50.21 Million | ▼ -25.8% |
| 2015 | $424.45 Million | $474.79 Million | $50.33 Million | ▲ +103.4% |
| 2014 | $208.70 Million | $243.03 Million | $34.33 Million | ▲ +73.3% |
| 2013 | $120.41 Million | $154.68 Million | $34.27 Million | ▼ -22.0% |
| 2012 | $154.37 Million | $195.98 Million | $41.61 Million | ▲ +156.9% |
| 2011 | $60.08 Million | $138.37 Million | $78.29 Million | ▲ +210.6% |
| 2010 | $19.34 Million | $144.42 Million | $125.08 Million | ▲ +389.3% |
| 2009 | $3.95 Million | $70.82 Million | $66.86 Million | ▼ -89.2% |
| 2008 | $36.77 Million | $118.18 Million | $81.41 Million | ▼ -69.0% |
| 2007 | $118.70 Million | $276.65 Million | $157.96 Million | ▼ -62.3% |
| 2006 | $314.72 Million | $389.68 Million | $74.96 Million | ▼ -19.3% |
| 2005 | $390.10 Million | $483.12 Million | $93.02 Million | ▼ -0.9% |
| 2004 | $393.83 Million | $519.22 Million | $125.39 Million | ▲ +0.7% |
| 2003 | $391.12 Million | $554.96 Million | $163.84 Million | ▲ +74.4% |
| 2002 | $224.25 Million | $266.54 Million | $42.28 Million | ▼ -27.8% |
| 2001 | $310.39 Million | $346.35 Million | $35.96 Million | ▲ +90.2% |
| 2000 | $163.21 Million | $185.96 Million | $22.75 Million | ▲ +69.3% |
| 1999 | $96.40 Million | $109.20 Million | $12.80 Million | ▲ +33.9% |
| 1998 | $72.00 Million | $80.50 Million | $8.50 Million | ▼ -13.5% |
| 1997 | $83.20 Million | $91.90 Million | $8.70 Million | ▲ +14.3% |
| 1996 | $72.80 Million | $78.00 Million | $5.20 Million | — |